Literature DB >> 6653944

Failure to find amyloidosis in dogs treated with long-term intravenous insulin delivered by a totally implantable pump.

S M Mauer, H Buchwald, T J Groppoli, T D Rohde, B D Wigness, W M Rupp, M W Steffes.   

Abstract

We examined tissues of seven non-diabetic mongrel dogs and four diabetic beagle dogs treated with constant insulin infusion via totally implantable pumps for from 210 to 880 days. Kidney and skeletal muscle tissue from all dogs were stained with Congo Red and thioflavin-T and appropriately examined. Kidney tissues from the beagle dogs were examined by electron microscopy. No amyloid deposits were found in any of these tissues. Thus, we cannot confirm an earlier report of amyloid occurring in dogs given long-term intravenous insulin. It is concluded that amyloidosis is not a necessary complication of long-term intravenous insulin infusion in dogs.

Entities:  

Mesh:

Year:  1983        PMID: 6653944     DOI: 10.1007/BF00282527

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

1.  Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils.

Authors:  G G Glenner; E D Eanes; H A Bladen; R P Linke; J D Termine
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

2.  Meticulous control of diabetes: benefits, risks, and precautions.

Authors:  R H Unger
Journal:  Diabetes       Date:  1982-06       Impact factor: 9.461

3.  The peritoneum--a potential insulin delivery route for a mechanical pancreas.

Authors:  D S Schade; R P Eaton
Journal:  Diabetes Care       Date:  1980 Mar-Apr       Impact factor: 19.112

4.  Implantable insulin pump: insulin infusion in animals and man.

Authors:  H Buchwald; W M Rupp; T D Rohde; J Barbosa; B D Wigness; F D Dorman; H B McCarthy; F J Goldenberg; P J Blackshear; R L Varco; M W Steffes; S M Mauer
Journal:  Trans Am Soc Artif Intern Organs       Date:  1982

5.  The use of an implantable insulin pump in the treatment of type II diabetes.

Authors:  W M Rupp; J J Barbosa; P J Blackshear; H B McCarthy; T D Rohde; F J Goldenberg; T G Rublein; F D Dorman; H Buchwald
Journal:  N Engl J Med       Date:  1982-07-29       Impact factor: 91.245

6.  Unanticipated amyloidosis in dogs infused with insulin.

Authors:  A M Albisser; K P McAdam; K Perlman; S Carson; A Bahoric; J R Williamson
Journal:  Diabetes       Date:  1983-12       Impact factor: 9.461

7.  A double balloon catheter technique for alloxan diabetogenesis in the dog.

Authors:  B D Wigness; S M Mauer; W M Rupp; T D Rohde; M W Steffes; P J Blackshear; R D Rucker; K Jeraj; H Buchwald
Journal:  Surg Gynecol Obstet       Date:  1982-12

8.  No evidence of amyloidosis in type I diabetics treated with continuous subcutaneous insulin infusion.

Authors:  V A Koivisto; A M Teppo; C P Maury; M R Taskinen
Journal:  Diabetes       Date:  1983-01       Impact factor: 9.461

9.  Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy.

Authors:  R A Rizza; J E Gerich; M W Haymond; R E Westland; L D Hall; A H Clemens; F J Service
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

10.  Diabetic nephropathy in the uninephrectomized dog: microscopic lesions after one year.

Authors:  M W Steffes; H Buchwald; B D Wigness; T J Groppoli; W M Rupp; T D Rohde; P J Blackshear; S M Mauer
Journal:  Kidney Int       Date:  1982-05       Impact factor: 10.612

View more
  3 in total

Review 1.  Recent developments in insulin delivery techniques. Current status and future potential.

Authors:  F P Kennedy
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

2.  Continuous subcutaneous insulin infusion does not induce a significant acute phase response of serum amyloid A protein.

Authors:  J J Bending; J C Pickup; I F Rowe; R Gallimore; G Tennent; H Keen; M B Pepys
Journal:  Diabetologia       Date:  1985-02       Impact factor: 10.122

3.  Effect of contact material on vibration-induced insulin aggregation.

Authors:  V Feingold; A B Jenkins; E W Kraegen
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.